Kefeng Dou
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 2%
- Liver physiology and pathology
Papers in
-
- Circular RNAs in diseases 6
- Epigenetics and DNA Methylation 5
- RNA modifications and cancer 4
- Surgery 22
- Organ Transplantation Techniques and Outcomes 9
- Xenotransplantation and immune response 5
- Co-authors
- Xisheng Yang (7 shared papers)Haimin Li (5 shared papers)Xiaolei Li (2 shared papers)Jianlin Wang (7 shared papers)Shibin Qu (5 shared papers)Runze Shang (4 shared papers)Yuan Gao (1 shared paper)Wei Sun (1 shared paper)
- Journals
- PLoS ONE (4 papers)Tumor Biology (4 papers)Cancer Letters (3 papers)Hepatology (3 papers)Advances in Therapy (2 papers)
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Kefeng Dou
100 papers receiving 4.3k citations
Kefeng Dou's Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 1.7k
- Hepatology 425
- Molecular Biology 2.8k
- Immunology 356
- Oncology 366
Countries citing papers authored by Kefeng Dou
This map shows the geographic impact of Kefeng Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kefeng Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kefeng Dou more than expected).
Fields of papers citing papers by Kefeng Dou
This network shows the impact of papers produced by Kefeng Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kefeng Dou. The network helps show where Kefeng Dou may publish in the future.
Co-authors
The 25 scholars most cited alongside Kefeng Dou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Circular RNA: A new star of noncoding RNAs Hit paper breakdown → | 2015 | 1427 |
| 2 | 2017 | 246 | |
| 3 | 2017 | 225 | |
| 4 | 2013 | 143 | |
| 5 | 2018 | 115 | |
| 6 | 2012 | 105 | |
| 7 | 2012 | 98 | |
| 8 | 2012 | 82 | |
| 9 | 2010 | 80 | |
| 10 | 2017 | 75 | |
| 11 | 2010 | 75 | |
| 12 | 2009 | 74 | |
| 13 | 2011 | 68 | |
| 14 | 2016 | 64 | |
| 15 | 2013 | 63 | |
| 16 | 2010 | 55 | |
| 17 | 2020 | 54 | |
| 18 | 2016 | 52 | |
| 19 | 2012 | 51 | |
| 20 | 2008 | 47 |
About Kefeng Dou
Kefeng Dou is a scholar working on Molecular Biology, Surgery, Cancer Research, Hepatology and Oncology, having authored 101 papers that have together received 4.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Liver physiology and pathology (10 papers), Organ Transplantation Techniques and Outcomes (9 papers), Circular RNAs in diseases (6 papers), Epigenetics and DNA Methylation (5 papers), Xenotransplantation and immune response (5 papers), Cancer-related molecular mechanisms research (5 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (1.7k citations), Hepatology (425 citations), Molecular Biology (2.8k citations), Immunology (356 citations) and Oncology (366 citations). Kefeng Dou has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Xisheng Yang, Haimin Li, Xiaolei Li, Jianlin Wang, Shibin Qu, Runze Shang, Yuan Gao, Wei Sun, Desheng Wang and Kaishan Tao. Their work appears in journals such as PLoS ONE, Tumor Biology, Cancer Letters, Hepatology and Advances in Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.